ISSN: 2576-1463

革新的なエネルギーと研究

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Analysis: Magnetic Resonance Targets Telomeres/Telomerase for Cancer Treatment?

Jacobson JI

This paper essentially poses the question, “Is it possible to calculate target-specific magnetic resonance energies to restore bio molecular order and inhibit telomerase production under conditions of increasing entropy, even as cells pass M2 checkpoints?” Indeed, a diversity of positive experimental outcomes has pointed to the possibility that non-ionizing radiation (NIR’s) produce positive bio effects of predictable nature. The hypothetical construct is that Pico-Tesla range magnetic fields are physiologic and may possibly affect molecules and molecular assemblies through the piezoelectric effect; most especially due to the supposed quasi-crystalline semi conductive nature of various biological structures. The initial physical mechanism is hypothesized to be photon-phonon transductions, i.e., electro mechanical conversions, via resonance phenomena. Utilizing a novel particle-wave equation, mc2=BvLq, specified magnetic flux densities have been calculated, formulating a possible system of dual resonance. The energy produced by the interaction of the organism and the magnetic field is set equal to the intrinsic energy of a molecule. The outcome of this methodology may possibly provide a new, noninvasive holistic paradigm for adjuvant treatment of cancer. In support of said hypothesis, various experimental outcomes are considered, wherein the given method was utilized to establish magnetic resonance protocols, based on molecular species known to be associated with pathophysiologic conditions including cancer. Thus, if successful, then a possible new adjunctive, non-invasive and non-significant risk approach for telomerase inhibition with conventional cancer therapy is proposed.